Craig-Hallum Maintains Veracyte(VCYT.US) With Buy Rating, Maintains Target Price $45
Craig-Hallum Reaffirms Their Buy Rating on Veracyte (VCYT)
Guggenheim Maintains Veracyte(VCYT.US) With Buy Rating, Cuts Target Price to $37
Guggenheim Maintains Buy on Veracyte, Lowers Price Target to $37
Veracyte Analyst Ratings
Veracyte Price Target Maintained With a $45.00/Share by Stephens & Co.
Craig-Hallum Initiates Veracyte(VCYT.US) With Buy Rating, Announces Target Price $45
Veracyte Analyst Ratings
Craig-Hallum Initiates Veracyte at Buy With $45 Price Target
Morgan Stanley Maintains Veracyte(VCYT.US) With Sell Rating, Raises Target Price to $29
Scotiabank Maintains Veracyte(VCYT.US) With Buy Rating, Maintains Target Price $44
Veracyte (VCYT) Gets a Buy From Scotiabank
Veracyte's Strong Market Position and Growth Potential Drive Buy Rating
Guggenheim Maintains Veracyte(VCYT.US) With Buy Rating, Raises Target Price to $45
Guggenheim Remains a Buy on Veracyte (VCYT)
UBS Maintains Veracyte(VCYT.US) With Buy Rating, Raises Target Price to $49
Veracyte Is Maintained at Buy by UBS
Guggenheim Reiterates Buy on Veracyte, Maintains $45 Price Target
Veracyte Analyst Ratings
Needham Maintains Veracyte(VCYT.US) With Buy Rating, Maintains Target Price $51